Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PriceSpective appoints Bob Nordyke to lead new unit

This article was originally published in Scrip

Executive Summary

PriceSpective, a consultancy providing pricing and reimbursement services to pharmaceutical, biotechnology and healthcare companies, has appointed Bob Nordyke to lead its new Health Economics and Outcomes Research (HEOR) practice. He has more than 18 years' HEOR experience, having previously worked as part of the global health economics team at Amgen where he served in various roles, including therapeutic area head for inflammation, global payer lead and global health economics lead for haematology/oncology and programme lead for EMR-based registry capability for oncology. Before Amgen, Mr Nordyke was director of outcomes research at Cerner LifeSciences and a research fellow at the RAND Corporation.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts